UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000013502
Receipt No. R000015609
Scientific Title Phase II study of erlotinib as first line chemotherapy in patients with lung adenocarcinoma with brain metastasis and EGFR mutations.
Date of disclosure of the study information 2014/03/25
Last modified on 2018/09/26 09:20:13

No. Disposal Last modified on Item of update
1 Insert 2014/03/24 22:35:41
2 Update 2016/05/23 21:08:34 Email
Email
Name of primary sponsor
Organization
3 Update 2018/09/26 09:20:13 Recruitment status


Contact us.